‘‘(2) TEMPORARY SUSPENSION.—The Secretary 
may require that importation of a specific qualifying 
prescription drug or importation by a specific cer-
tified foreign seller or importer pursuant to this sec-
tion be temporarily suspended if, with respect to 
such drug, seller, or importer, there is a violation of 
any requirement of this section or if the Secretary 
determines that importation of such drug or by such 
seller or importer might endanger the public health. 
Such temporary suspension shall apply until the Sec-
retary completes an investigation and determines 
that importation of such drug or by such seller or 
importer does not endanger the public health. 
‘‘(k) SUPPLY CHAIN SECURITY.— 
‘‘(1) PURCHASE FROM REGISTERED FACILITIES 
AND CERTIFIED FOREIGN SELLERS.— 
‘‘(A) IN GENERAL.—Except as provided in 
subparagraph (B), certified foreign sellers who 
sell qualifying prescription drugs for importa-
tion into the United States pursuant to this 
section may purchase such drugs only from 
manufacturers or entities registered under sec-
tion 510 or other certified foreign sellers. 
‘‘(B) EXCEPTION.—Certified foreign sellers 
who sell qualifying prescription drugs for im-
VerDate Sep 11 2014 
03:51 May 27, 2021
Jkt 019200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H2181.IH
H2181
pbinns on DSKJLVW7X2PROD with BILLS
portation into the United States pursuant to 
this section may purchase such drugs from for-
eign sellers in Canada or another permitted 
country, even if such foreign seller is not a 
manufacturer registered under section 510 or a 
certified foreign seller, if the Secretary enters 
into a memorandum of understanding or coop-
erative agreement with Canada, or such other 
permitted country, to ensure compliance, to the 
extent appropriate and feasible, with subchapter 
H of chapter V. The Secretary shall seek to 
enter into such a memorandum of under-
standing or cooperative agreement with Canada 
and each country from which importation is 
permitted under subsection (e). 
‘‘(2) IMPORTATION TRACING.—Certified foreign 
sellers shall provide importers with the unique facil-
ity identifier associated with the manufacturer reg-
istered under section 510 of the qualifying prescrip-
tion drug and the information under paragraph 
(25), paragraph (26) (other than subparagraph (C)), 
and subparagraphs (D), (F), and (G) of paragraph 
(27) of section 581. Certified foreign sellers shall 
provide such information to individuals purchasing 
such drugs, upon request. 
VerDate Sep 11 2014 
03:51 May 27, 2021
Jkt 019200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H2181.IH
H2181
pbinns on DSKJLVW7X2PROD with BILLS
‘‘(l) REMS.—In the case of an importer that imports 
a qualifying prescription drug, where the drug with the 
same active ingredient or ingredients (or that is biosimilar 
to an approved biological product), route of administra-
tion, and strength that is approved under chapter V or 
section 351 of the Public Health Service Act is subject 
to elements to assure safe use under section 505–1, such 
importer shall be subject to such elements to assure safe 
use, as applicable and appropriate. 
‘‘(m) CONSTRUCTION.—Nothing in this section limits 
the authority of the Secretary relating to the importation 
of prescription drugs, other than with respect to section 
801(d)(1) as provided in this section.’’. 
(b) PENALTIES WITH RESPECT TO ONLINE PHAR-
MACIES.—Section 303 of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 333) is amended by adding at 
the end the following: 
‘‘(h) In the case of person operating an internet 
website, whether in the United States or in another coun-
try, that violates section 301(aa) by— 
‘‘(1) selling, by means of the internet, with the 
intent to defraud or mislead or with reckless dis-
regard for safety of the public, an adulterated or 
counterfeit drug to an individual in the United 
States; or 
VerDate Sep 11 2014 
03:51 May 27, 2021
Jkt 019200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H2181.IH
H2181
pbinns on DSKJLVW7X2PROD with BILLS
‘‘(2) dispenses, by means of the internet, a drug 
to an individual in the United States who the person 
knows or has reasonable cause to believe, does not 
possess a valid prescription for that drug, 
such person shall be imprisoned for not more than 10 
years or fined not more than $250,000.’’. 
(c) NO PREEMPTION.—Nothing in this Act, including 
the amendments made by this Act, shall be construed to 
preempt, alter, displace, abridge, or supplant any remedy 
available under any State or Federal law, including com-
mon law, that provides a remedy for civil relief. 
(d) REPORTS.— 
(1) HHS.—Not later than 1 year after the date 
on which final regulations are promulgated to carry 
out section 804 of the Federal Food, Drug, and Cos-
metic Act (21 U.S.C. 384), as amended by this Act, 
and every 2 years thereafter, the Secretary of 
Health and Human Services, after consultation with 
appropriate Federal agencies, shall submit to Con-
gress and make public a report on the importation 
of drugs into the United States. 
(2) GAO REPORT.—Not later than 18 months 
after the date on which final regulations are promul-
gated to carry out section 804 of the Federal Food, 
Drug, and Cosmetic Act (21 U.S.C. 384), as amend-
VerDate Sep 11 2014 
03:51 May 27, 2021
Jkt 019200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H2181.IH
H2181
pbinns on DSKJLVW7X2PROD with BILLS
ed by this Act, the Comptroller General of the 
United States shall submit to Congress a report con-
taining an analysis of the implementation of the 
amendments made by this Act, including a review of 
drug safety and cost-savings and expenses, including 
cost-savings to consumers in the United States and 
trans-shipment and importation tracing processes, 
resulting from such implementation. 
Æ 
VerDate Sep 11 2014 
03:51 May 27, 2021
Jkt 019200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6301
E:\BILLS\H2181.IH
H2181
pbinns on DSKJLVW7X2PROD with BILLS